THE ROLE OF ESTROGEN IN HEPATIC LIPID METABOLISM: CLINICAL IMPLICATIONS FOR POSTMENOPAUSAL WOMEN

Yuldasheva Dildara Daliquzievna; Suyunov Og’abek Oybek o’g’li

Authors

Yuldasheva Dildara Daliquzievna Author
Suyunov Og’abek Oybek o’g’li Author

Abstract

Estrogen is a major endocrine regulator that contributes to multiple physiological processes, including the control of lipid metabolism within the liver. During menopause, circulating estrogen levels decline markedly, leading to significant metabolic alterations. These changes include increased hepatic fat accumulation, dyslipidemia, and a higher risk of metabolic dysfunction-associated steatotic liver disease. Clinical and epidemiological studies indicate that postmenopausal women experience a greater incidence of hepatic metabolic disorders compared with women of reproductive age. This article examines the biological mechanisms through which estrogen regulates hepatic lipid metabolism and evaluates clinical data regarding the metabolic consequences of estrogen deficiency. In addition, the potential benefits and limitations of hormone replacement therapy are analyzed. Understanding the role of estrogen in hepatic metabolism may support the development of gender-specific strategies aimed at preventing metabolic disorders in aging female populations.

References

1. Della Torre, S., Mitro, N., Fontana, R., Gomaraschi, M., Favari, E., Recordati, C., Lolli, F., Quagliarini, F., Meda, C., Ohlsson, C., & Maggi, A. (2016). An essential role for liver ERα in coupling hepatic metabolism to the reproductive cycle. Cell Reports, 15(2), 360–371.

2. Palmisano, B. T., Zhu, L., Stafford, J. M. (2017). Role of estrogen in the regulation of liver lipid metabolism. Advances in Experimental Medicine and Biology, 1043, 227–256.

3. Mauvais-Jarvis, F. (2015). Sex differences in metabolic homeostasis, diabetes, and obesity. Biology of Sex Differences, 6(1), 14.

4. Lonardo, A., Nascimbeni, F., Ballestri, S., Fairweather, D., Win, S., Than, T. A., Abdelmalek, M. F., Suzuki, A. (2019). Sex differences in nonalcoholic fatty liver disease: State of the art and identification of research gaps. Hepatology, 70(4), 1457–1469.

5. Zhu, L., Brown, W. C., Cai, Q., Krust, A., Chambon, P., McGuinness, O. P., Stafford, J. M. (2013). Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Diabetes, 62(2), 424–434.

6. Kim, C., Halter, J. B. (2014). Endogenous sex hormones, metabolic syndrome, and diabetes in men and women. Current Cardiology Reports, 16(4), 467.

7. Carr, M. C. (2003). The emergence of the metabolic syndrome with menopause. Journal of Clinical Endocrinology & Metabolism, 88(6), 2404–2411.